Clinical Study on Acupuncture Treatment of Retinitis Pigmentosa

Not Applicable

Recruiting

• Conditions: Retinitis Pigmentosa

• Registration Number: ITMCTR2000004174
• Lead Sponsor: Hospital of Chengdu University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria of primary retinitis pigmentosa;
2. Age 7-80 years old, the course of disease is not limited to men and women;
3. The process of obtaining the informed consent is in line with the requirements of clinical trial management standards.

Exclusion Criteria

1. The BCVA is less than 0.1;
2. Having other ophthalmic diseases such as amblyopia, diabetic retinopathy, glaucoma, severe cataract and other eye diseases that affect vision or cause blindness;
3. Patients with severe primary diseases such as cardiovascular and cerebrovascular diseases, liver and kidney diseases and hematopoietic systems;
4. Patients who use other relevant drugs or treat primary retinitis pigmentosa within 2 weeks;
5. Poor compliance, or participating in other clinical trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BCVA;View of MS, MD;

Secondary Outcome Measures

Name	Time	Method
ERG;SFCT;SQL-VI;CMT;TCM syndrome complex integral;